Study identifies a significant link between higher atherogenic index of plasma (AIP) levels and increased erectile dysfunction (ED) risk among US men, with implications for early intervention and cardiovascular health.
Iovance’s LN-145 poised for accelerated approval in relapsed NSCLC patients – Pharmaceutical Technology
The therapy is currently being evaluated in Phase ll studies for various indications such as triple-negative breast cancer, thyroid cancer, and other bone or soft